11.00
前日終値:
$11.03
開ける:
$11.05
24時間の取引高:
42,197
Relative Volume:
1.07
時価総額:
$44.48M
収益:
$147.75M
当期純損益:
$-284.23M
株価収益率:
-3.7543
EPS:
-2.93
ネットキャッシュフロー:
$-317.54M
1週間 パフォーマンス:
-0.09%
1か月 パフォーマンス:
+4.27%
6か月 パフォーマンス:
+42.86%
1年 パフォーマンス:
+36.22%
Fibrogen Inc Stock (FGEN) Company Profile
FGEN を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
FGEN
Fibrogen Inc
|
11.00 | 44.60M | 147.75M | -284.23M | -317.54M | -2.93 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.20 | 103.89B | 11.74B | 3.68B | 3.34B | 14.19 |
|
REGN
Regeneron Pharmaceuticals Inc
|
654.74 | 69.11B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
441.70 | 58.49B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
869.83 | 52.62B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
191.92 | 40.46B | 447.02M | -1.18B | -906.14M | -6.1812 |
Fibrogen Inc Stock (FGEN) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2023-08-08 | ダウングレード | BofA Securities | Neutral → Underperform |
| 2023-06-26 | ダウングレード | BofA Securities | Buy → Neutral |
| 2023-06-26 | ダウングレード | Raymond James | Outperform → Mkt Perform |
| 2023-06-26 | ダウングレード | Stifel | Buy → Hold |
| 2023-06-26 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2023-06-02 | アップグレード | Stifel | Hold → Buy |
| 2023-01-31 | アップグレード | William Blair | Mkt Perform → Outperform |
| 2023-01-26 | アップグレード | Raymond James | Mkt Perform → Outperform |
| 2023-01-05 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-09-22 | ダウングレード | Goldman | Neutral → Sell |
| 2021-08-20 | アップグレード | Raymond James | Underperform → Mkt Perform |
| 2021-07-16 | ダウングレード | BofA Securities | Buy → Neutral |
| 2021-07-16 | ダウングレード | Stifel | Buy → Hold |
| 2021-04-07 | ダウングレード | H.C. Wainwright | Buy → Neutral |
| 2021-04-07 | ダウングレード | Mizuho | Buy → Neutral |
| 2021-03-31 | アップグレード | BofA Securities | Neutral → Buy |
| 2021-03-02 | ダウングレード | Jefferies | Buy → Hold |
| 2021-02-01 | 開始されました | H.C. Wainwright | Buy |
| 2020-10-26 | 開始されました | Raymond James | Underperform |
| 2020-07-10 | 再開されました | Stifel | Buy |
| 2020-05-01 | 開始されました | Cowen | Market Perform |
| 2020-04-27 | 開始されました | BofA/Merrill | Neutral |
| 2019-05-29 | 再開されました | Goldman | Neutral |
| 2019-05-10 | ダウングレード | William Blair | Outperform → Mkt Perform |
| 2019-04-12 | 開始されました | Piper Jaffray | Neutral |
| 2019-02-11 | 再開されました | Stifel | Buy |
| 2018-12-19 | アップグレード | Citigroup | Neutral → Buy |
| 2017-08-08 | 繰り返されました | Leerink Partners | Outperform |
| 2017-08-08 | 繰り返されました | Stifel | Buy |
| 2017-07-21 | ダウングレード | Goldman | Buy → Neutral |
| 2017-07-11 | 開始されました | Jefferies | Buy |
| 2016-02-11 | アップグレード | Credit Suisse | Neutral → Outperform |
| 2016-01-21 | 開始されました | Credit Suisse | Neutral |
| 2015-12-04 | 開始されました | Citigroup | Buy |
| 2015-09-23 | 開始されました | Lake Street | Hold |
| 2015-07-29 | 開始されました | Citigroup | Buy |
| 2015-07-20 | アップグレード | Goldman | Neutral → Buy |
| 2014-12-09 | 開始されました | Stifel | Buy |
すべてを表示
Fibrogen Inc (FGEN) 最新ニュース
FibroGen Inc (FGEN) Q3 2025 Earnings Call Highlights: Strategic Moves Bolster Financial ... - Yahoo Finance
FibroGen’s Strategic Moves and Financial Highlights - TipRanks
Earnings call transcript: FibroGen Q3 2025 sees revenue rise, cost cuts - Investing.com
FibroGen (FGEN) Reports Q3 Loss, Lags Revenue Estimates - sharewise.com
FibroGen: Q3 Earnings Snapshot - San Francisco Chronicle
FibroGen (FGEN) Q3 Revenue Falls Short, Advances Key Trials - GuruFocus
FibroGen Sells China Unit To AstraZeneca And Refocuses - Finimize
FibroGen posts Q3 net income of $200.6 mln after sale of China operations - MarketScreener
FibroGen Reports Third Quarter 2025 Financial Results and Provides Business Update - The Globe and Mail
FibroGen (NASDAQ: FGEN) posts $1.1M revenue as China sale closes; cash runway into 2028 - Stock Titan
Backtesting results for FibroGen Inc. trading strategies2025 Pullback Review & Short-Term Trading Opportunity Alerts - newser.com
What does recent volatility data suggest for FibroGen Inc.Dollar Strength & Free Real-Time Market Sentiment Alerts - newser.com
What to expect from FibroGen Inc. in the next 30 daysTrade Risk Assessment & Daily Chart Pattern Signals - newser.com
Will earnings trigger a reversal in FibroGen Inc.July 2025 Snapshot & AI Forecasted Stock Moves - newser.com
What hedge fund activity signals for FibroGen Inc. stock2025 Breakouts & Breakdowns & AI Forecast for Swing Trade Picks - newser.com
Is FibroGen Inc. stock attractive for hedge fundsEarnings Summary Report & Weekly High Potential Alerts - newser.com
FibroGen (FGEN) Prepares for Q3 Earnings with Significant Revenue Decline - GuruFocus
Technical signs of recovery in FibroGen Inc.2025 Momentum Check & High Win Rate Trade Alerts - newser.com
Is FibroGen Inc. stock ready for a breakoutJuly 2025 Final Week & Technical Pattern Recognition Alerts - newser.com
FibroGen Receives $6.4 Million Payment from AstraZeneca - The Globe and Mail
Should you hold or exit FibroGen Inc. now2025 Earnings Impact & Free Long-Term Investment Growth Plans - newser.com
Why FibroGen Inc. stock attracts global investorsTrade Entry Report & Expert Approved Trade Ideas - newser.com
FibroGen Receives Payment from AstraZeneca - TradingView
Forecasting FibroGen Inc. price range with options dataEarnings Overview Report & Accurate Technical Buy Alerts - newser.com
Can FibroGen Inc. stock sustain institutional interest2025 Price Targets & Free Real-Time Volume Trigger Notifications - newser.com
Why retail investors favor FibroGen Inc. stockWeekly Stock Recap & Reliable Price Breakout Signals - Fundação Cultural do Pará
Does FibroGen Inc. stock trade at a discount to peersWeekly Profit Analysis & Community Verified Trade Signals - Fundação Cultural do Pará
How interest rate cuts could boost FibroGen Inc. stockJuly 2025 Catalysts & Short-Term Swing Trade Alerts - fcp.pa.gov.br
Will FibroGen Inc. (1FG0) stock keep raising dividendsJuly 2025 PostEarnings & Risk Managed Trade Strategies - Fundação Cultural do Pará
Can FibroGen Inc. stock outperform in 2025 bull marketJuly 2025 Earnings & Smart Money Movement Alerts - newser.com
Is FibroGen Inc. reversing from oversold territoryBear Alert & Real-Time Stock Movement Alerts - newser.com
How to read the order book for FibroGen Inc.Quarterly Trade Review & Capital Efficient Trading Techniques - newser.com
Chart based exit strategy for FibroGen Inc.Weekly Loss Report & Safe Capital Growth Tips - newser.com
Fibrogen Inc (FGEN) 財務データ
収益
当期純利益
現金流量
EPS
Fibrogen Inc (FGEN) インサイダートレーディング
| インサイダートレーディング | 関係 | 日付 | 取引 | コスト | #株式 | 値 ($) | #株式総数 |
|---|---|---|---|---|---|---|---|
| Wettig Thane | CEO |
Mar 24 '25 |
Buy |
0.35 |
145,000 |
50,663 |
543,329 |
| Schoeneck James A | Director |
Mar 20 '25 |
Buy |
0.35 |
250,000 |
88,000 |
323,722 |
| Schoeneck James A | Director |
Mar 21 '25 |
Buy |
0.34 |
50,000 |
17,040 |
373,722 |
大文字化:
|
ボリューム (24 時間):